• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

268.17 -2.63 (-0.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 515,453
Open 267.66
Bid (Size) 262.50 (40)
Ask (Size) 284.47 (40)
Prev. Close 270.80
Today's Range 265.31 - 271.40
52wk Range 239.25 - 385.22
Shares Outstanding 1,211,067,023
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BeOne Medicines Signals Solid Tumor Breakout as Three Programs Near Phase 3 ↗
June 02, 2026
BeOne Medicines (NASDAQ:ONC) used an investor event at ASCO to outline what executives described as a new phase of growth beyond hematology, highlighting three solid tumor programs that the company... 
Via MarketBeat
News headline image
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
June 01, 2026
From BeOne Medicines Ltd.
Via Business Wire

Performance

YTD
-13.8%
-13.8%
1 Month
-13.7%
-13.7%
3 Month
-11.3%
-11.3%
6 Month
-17.9%
-17.9%
1 Year
+1.7%
+1.7%

More News

Read More
News headline image
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
May 29, 2026
From BeOne Medicines Ltd.
Via Business Wire
BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini's SEPA Screen with Strong Technicals and High Growth Momentum ↗
February 26, 2026
Via Chartmill
News headline image
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
May 27, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
May 21, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
May 20, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares ↗
May 16, 2026
Via The Motley Fool
News headline image
What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗
May 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗
May 14, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗
May 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
May 13, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates
May 06, 2026
From BeOne Medicines Ltd
Via Business Wire
News headline image
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
April 29, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
BeOne Medicines to Announce First Quarter 2026 Financial Results on May 6
April 22, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗
March 19, 2026
Via The Motley Fool
News headline image
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
February 26, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
February 21, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗
February 20, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
BeOne Medicines to Present at Upcoming Investor Conferences
February 17, 2026
From BeOne Medicines Ltd.
Via Business Wire
News headline image
Prediction: These 3 Stocks Will Crush the Market in 2026 ↗
February 16, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
February 11, 2026
From BeOne Medicines Ltd.
Via Business Wire

Frequently Asked Questions

Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?
Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.
What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?
BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?
The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market
What is the current price of BeOne Medicines Ltd. - American Depositary Shares?
The current price of BeOne Medicines Ltd. - American Depositary Shares is 268.17
When was BeOne Medicines Ltd. - American Depositary Shares last traded?
The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 06/09/26 04:00 PM ET
What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?
The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 324.77B
How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?
BeOne Medicines Ltd. - American Depositary Shares has 325B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap